Although ethically unavoidable in RA patients, some csDMARDs, such as methotrexate for instance, were shown to significantly decrease serum levels of RF‐IgM and ‐IgA, thereby potentially underestimating the full magnitude of some correlations in this study.48 The gene discussed is CD40LG; the disease is rheumatoid arthritis.